Abstract
Background Decision-making in healthcare should include considerations for its environmental and social consequences as well as clinical and financial. Business cases represent projects which are likely to have particularly high impact, in which performing an Environmental and Social Impact Assessment may reduce negative effects. The practice of assessing these impacts is not mandatory, therefore our aim was to determine to what extent environmental and social considerations are incorporated into business planning across NHS trusts in England. We also set out to identify examples of good practice, common challenges and possible solutions to overcome these.
Methods We conducted a cross-sectional survey across trusts in NHS England to capture current practice. This was carried out online between April and July 2024.
Results Ninety seven out of 210 trusts (46%) responded to the survey. Thirty two currently assess the environmental and/or social impact of their business cases and 25 are in the process of doing so, illustrating a growing practice. There is significant variation between trusts in terms of content, format and process of the assessment.
Discussion This was the first study to portray not only whether and how environmental and social impacts are assessed in NHS business planning, but also the barriers and potential solutions in embedding this assessment. The variation in practice signifies heterogeneity of NHS trusts and there is unlikely to be a single tool that would suit every organisation. An impact assessment process with a clear purpose, that reflects organisational values, and is supported by multidisciplinary expertise is likely to be more meaningful. We include an Environmental and Social Impact Assessment tool for our trust, which has been developed based on the learning points from this study and modified to our trust’s needs, as an example.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee Joint Research Office of Oxford University Hospitals NHS Foundation Trust waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Revision made to Results section due to duplication in previous version
Data Availability
All data produced in the present study are available upon reasonable request to the authors
